Cite
HARVARD Citation
Antlanger, M. et al. (2022). Combined sodium glucose co‐transporter‐2 inhibitor and angiotensin‐converting enzyme inhibition upregulates the renin‐angiotensin system in chronic kidney disease with type 2 diabetes: Results of a randomized, double‐blind, placebo‐controlled exploratory trial. Diabetes, obesity & metabolism. 24 (5), pp. 816-826. [Online].